Our fair value estimate is $101 per share, which is roughly 13 times 2025 adjusted EPS, representing a significant discount relative to the US multi-industrial category and 3M’s peers, which we view ...

Cardano & Neo Pepe Lead Crypto Charge As cryptocurrency markets warm up for what could be the next substantial bullish cycle, investor focus has sharpened o ...

FARTCOIN faces rising bearish pressure after a $2.3 million whale selloff, weakening market sentiment and fueling concerns ...

Best Nikon Camera Price: Nikon being one of the best camera brands has never failed to serve excellence with constant improvement in its technology. In this guide, we’ve got you covered with a Nikon ...

Aksha Kamboj, Vice President at the India Bullion and Jewellers Association, added that unless there’s a major flare-up in global tensions, gold may continue to trade in a narrow range. “Prices are ...

M Company’s MMM shares have gained 40.2% over the past year, outperforming the S&P 500’s growth of 9.4% and the Zacks Diversified Operations industry’s growth of 3%. The diversified technology company ...

Royal Enfield Bullet 350 prices hiked, new range costs ₹1.75 to ₹2.18 lakh Royal Enfield has increased the Bullet 350's price by ₹ 2,000 to ₹ 3,000.

Bajaj Chetak 3001 vs rivals: price Three scooters here priced below the Rs 1 lakh mark The new Chetak 3001 has a rather affordable price tag, but today’s EV landscape is quite competitive and ...

Caris Life Sciences Inc., a health-care company that uses technology to help diagnose and treat cancer, raised $494 million in a US initial public offering that priced above the top of its marketed ...

Southwest Gas (NYSE:SWX) is selling 9.75M existing shares of Centuri's (NYSE:CTRI) common stock at a price of $20.75 a share in an underwritten secondary public offering. The offering was upsized ...

Nexchain – Stage 18 Token With 429% ROI and $0.07 Entry Nexchain is capturing investor attention not with hype, but with real tech and measurable upside. Now in Stage 18 of its crypto presale, ...

Cancer diagnostic firm Caris Life Sciences said on Monday it was targeting a valuation of $5.67 billion in its U.S. initial public offering, after raising its proposed price range.